팝업레이어 알림이 없습니다.

팝업레이어 알림

팝업레이어 알림이 없습니다.
최근탈모소식

탈모치료제 피나스테리드 복용이 전립선암 발생을 줄여준다는 논문발표입니다.^^

페이지 정보

611

본문

탈모치료를 위한 프로체시아 복용을한 55세이상의 19000명을 대상으로 한 18년간의 연구결과
전립선암을 30%가량 줄여 줄수있다는 결론을 내렸습니다.
자세한 원문은 아래와 같으나 골자는 다음과 같습니다.
탈모환자들이 약을 먹어서 좋아지는 한가지 이유가 더 더해졌네요.^^

 

 

Study: Hair Loss Drug Propecia (Finasteride) Reduces Prostate Cancer Risk
Category: Hair Loss Blog , Hair Loss News , Non Surgical Treatments , Propecia (Finasteride)
Finasteride-Propecia-ProscarAn 18 year study of approximately 19,000 men aged 55 and older recently concluded that that the hair loss drug Propecia (finasteride) may reduce the risk of prostate cancer in some men by up to 30%.

A portion of the participants were given finasteride while the rest were given a placebo. The men given the drug had only a 10 percent rate of contracting prostate cancer while those who took the placebo had a 15 percent rate of contracting the disease.

The study, published in the New England Journal of Medicine also determined that the ten year survival of participants diagnosed with prostate cancer was equivalent between the control and placebo groups overall (78 percent). In those with low-grade cancers the survival rate was 82 percent and in those with high-grade cancers, 73 percent.

The small excess of higher grade tumors in the men taking finasteride did not effectively translate into an increased risk of death. This finding seems to counter previous research suggesting finasteride increases the risk of dying from an aggressive form of the disease due to prostate gland shrinkage and increased sensitivity in detecting higher grade cancers.

Perhaps these findings may one day revive the practice of prescribing finasteride for the prevention of prostate cancer, saving thousands of lives annually.